Ms. Matsui (for herself, Mr. Crenshaw, Ms. Schrier, and Mrs. Hinson) introduced the following bill; which was referred to the Committee on Energy and Commerce
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Drug Origin Transparency Act of 2026. H.R. 8339. 119th
Cong., 2nd
sess., Introduced in House April 16, 2026. https://www.govinfo.gov/app/details/BILLS-119hr8339ih.
APA
Congress, House of Representatives (2026, April 16). Drug Origin Transparency Act of 2026 (H.R. 8339 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr8339ih.
MLA
United States, Congress, House of Representatives. Drug Origin Transparency Act of 2026. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr8339ih. 119th Congress, H.R. 8339, Introduced in House 16 Apr. 2026.
Bluebook
H.R.8339 - 119th Congress (2025-2026): Drug Origin Transparency Act of 2026, H.R.8339, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr8339ih.
